Search Results: PARP

• Health & Medicine
• Science & Technology

Scientists exploit leaks in blood brain barrier to treat glioblastoma

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma. An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma.

6 November 2017

• Health & Medicine
• Science & Technology

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer. In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

9 September 2017

• Health & Medicine

Targeted drug helps keep some advanced ovarian cancers at bay

Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening. Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.

8 September 2017

• For Researchers

Rucaparib: targeting DNA repair and a patient's perspective

Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib. Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib.

21 July 2017

• Charity News

Reviewing our year

Read about some of the progress we've made over the last financial year and about some of the big themes from the year. Read about some of the progress we've made over the last financial year and about some of the big themes from the year.

20 July 2017

• Health & Medicine

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer. Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

19 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017

• For Researchers

Honouring a giant of translational research: Stan Kaye

In 2016 we awarded our Lifetime Achievement in Cancer Research Prize to Professor Stan Kaye, who has made exceptional advances in cancer drug development. In 2016 we awarded our Lifetime Achievement in Cancer Research Prize to Professor Stan Kaye, who has made exceptional advances in cancer drug development.

19 May 2017

• Science & Technology

PARG inhibitors: tipping the scales with a new experimental drug

Our scientists are developing a new experimental drug to target how cancer cells repair their DNA, and upset cancer's balance. Our scientists are developing a new experimental drug to target how cancer cells repair their DNA, and upset cancer's balance.

16 March 2017

• Science & Technology

More breast cancer patients than previously thought could benefit from existing targeted treatment

As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates. As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.

13 March 2017

• Health & Medicine

Ovarian cancer drug could target gene fault in brain tumours

A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest. A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest.

1 February 2017